Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,586,162
+$5,458,145 QoQ
Shares Held
581,338
+61.1% QoQ
Ownership
0.903%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 183 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. CGEM ranks #51 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in CGEM

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,586,162 581,338
2026-03-31 $5,128,017 360,874
2025-12-31 $2,913,346 281,483
2025-09-30 $1,173,662 197,920
2025-06-30 $157,526 20,920
2023-09-30 $197,054 21,774
2023-06-30 $772,804 71,822
2023-03-31 $903,227 88,292
2022-12-31 $1,174,848 111,360
2022-09-30 $1,389,713 108,402
2022-06-30 $268,053 20,909